Canaccord Genuity Group Lowers Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $11.00
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price objective decreased by research analysts at Canaccord Genuity Group from $34.00 to $11.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price target points to a […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) had its price objective decreased by research analysts at Canaccord Genuity Group from $34.00 to $11.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price target points to a […]
